(Q39535054)

12 September 2017

Metformin stimulates osteoprotegerin and reduces RANKL expression in osteoblasts and ovariectomized rats (English)

1 reference

12 September 2017

0 references

1 reference

Qi-Guang Mai

1

1 reference

12 September 2017

Zhong-Min Zhang

2

1 reference

12 September 2017

Song Xu

3

1 reference

12 September 2017

Ming Lu

4

1 reference

12 September 2017

Rong-Ping Zhou

5

1 reference

12 September 2017

Li Zhao

6

1 reference

12 September 2017

Chun-Hong Jia

7

1 reference

12 September 2017

Zhi-Hua Wen

8

1 reference

12 September 2017

Da-Di Jin

9

1 reference

12 September 2017

Xiao-Chun Bai

10

1 reference

12 September 2017

1 October 2011

1 reference

Journal of Cellular Biochemistry

12 September 2017

1 reference

12 September 2017

112

1 reference

12 September 2017

10

1 reference

12 September 2017

2902-2909

1 reference

Reactive oxygen species stimulates receptor activator of NF-kappaB ligand expression in osteoblast

12 September 2017

1 reference

Rheb activates mTOR by antagonizing its endogenous inhibitor, FKBP38.

21 January 2018

1 reference

The effect of metformin on alveolar bone in ligature-induced periodontitis in rats: a pilot study

21 January 2018

1 reference

Osteogenic actions of the anti-diabetic drug metformin on osteoblasts in culture

21 January 2018

1 reference

Effect of the anti-diabetic drug metformin on bone mass in ovariectomized rats

21 January 2018

1 reference

Metformin enhances the differentiation and mineralization of osteoblastic MC3T3-E1 cells via AMP kinase activation as well as eNOS and BMP-2 expression

21 January 2018

1 reference

Diabetes and fractures: an overshadowed association

21 January 2018

1 reference

AMP kinase acts as a negative regulator of RANKL in the differentiation of osteoclasts

21 January 2018

1 reference

AMPK and transcriptional regulation.

21 January 2018

1 reference

Metastasis to bone: causes, consequences and therapeutic opportunities

21 January 2018

1 reference

Osteoporosis among patients with type 1 and type 2 diabetes

21 January 2018

1 reference

AMP-activated protein kinase (AMPK) activation regulates in vitro bone formation and bone mass

21 January 2018

1 reference

Osteoprotegerin: a novel secreted protein involved in the regulation of bone density

21 January 2018

1 reference

Osteoclastic function is accelerated in male patients with type 2 diabetes mellitus: the preventive role of osteoclastogenesis inhibitory factor/osteoprotegerin (OCIF/OPG) on the decrease of bone mineral density

21 January 2018

1 reference

Bone resorption by osteoclasts

21 January 2018

1 reference

Isolation of a novel cytokine from human fibroblasts that specifically inhibits osteoclastogenesis

21 January 2018

1 reference

Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL

21 January 2018

1 reference

Role of AMP-activated protein kinase in mechanism of metformin action

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/JCB.23206

1 reference

12 September 2017

1 reference